Characteristics of Malignant Thyroid Tumors: A Retrospective Study on 320 Patients
Papillary thyroid cancer accounts for 80-85% of diagnosed thyroid cancers, while follicular, medullary, and anaplastic cancers are diagnosed significantly less frequently. This study aimed to show the characteristics of malignant thyroid tumors. In this retrospective study, we analyzed data from...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2020-01-01
|
Series: | Acta Clinica Croatica |
Subjects: | |
Online Access: | https://hrcak.srce.hr/file/361386 |
Summary: | Papillary thyroid cancer accounts for 80-85% of diagnosed thyroid cancers, while
follicular, medullary, and anaplastic cancers are diagnosed significantly less frequently. This study
aimed to show the characteristics of malignant thyroid tumors. In this retrospective study, we analyzed
data from 320 patients who underwent thyroid surgery from January 2018 to December 2019. We
recorded and statistically analyzed basic demographic data, data of the cytological and pathohistological
findings, and tumor characteristics (size, multifocality, extrathyroidal and lymphovascular invasion).
Thyroid cancer was diagnosed in 95 patients. The incidence of thyroid cancer was higher in
women than in men, but without a significant difference (p=0.46). There was a significant difference
between preoperative cytological findings and definitive pathohistological diagnosis (p=0.001). There
was no significant difference between genders in tumor size, extrathyroidal and lymphovascular invasion,
and multifocality. There were significantly more thyroid cancers with a lymphovascular invasion
that were less than 2 cm in size (p=0.04). In our opinion, it is important to emphasize the value of
early diagnostics and analysis of the malignant tumor characteristics that are major prognostic factors
for survival in patients with thyroid cancer. |
---|---|
ISSN: | 0353-9466 1333-9451 |